Mind Medicine Q2 EPS $(0.76) Misses $(0.54) Estimate
Portfolio Pulse from totan@benzinga.com
Mind Medicine (NASDAQ:MNMD) reported Q2 losses of $(0.76) per share, missing the analyst consensus estimate of $(0.54) by 40.74 percent. This represents a 26.67 percent decrease over losses of $(0.60) per share from the same period last year.
August 04, 2023 | 2:26 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Mind Medicine's Q2 earnings were worse than expected, with losses of $(0.76) per share, missing the consensus estimate by 40.74%. This is a significant decrease from the same period last year.
Mind Medicine's Q2 earnings were significantly worse than expected, missing the consensus estimate by a large margin. This is likely to negatively impact investor sentiment and could lead to a decrease in the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100